U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients - Reuters.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZDNODET53FKDHLHCEWMGJ66CZI.jpg)
5/28/2022 12:00:00 AM2 years 11 months ago
Use of Pfizer Inc's <a href="https://www.reuters.com/companies/PFE.N" target="_blank">(PFE.N)</a> COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that …
May 28 (Reuters) - Use of Pfizer Inc's (PFE.N) COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency war… [+4162 chars]
full article...